SABBY Management, LLC, 10% Owner at Celsus Therapeutics Plc. (CLTX), bought 7,875 shares at $6.18 ($48K) on 2014-04-01, disclosed to the SEC on 2014-04-02.
Open-market purchase of $48k CLTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.08 | 7,375 | $45K | 93.6% |
| 2 | $6.18 | 500 | $3K | 6.4% |
| Total | $6.09 avg | 7,875 | $48K | 100% |
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |